{
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        807, 
        830
      ]
    }
  ], 
  "Comments Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1490, 
        1510
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        869, 
        896
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        575, 
        604
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1424, 
        1450
      ]
    }
  ], 
  "Neoplasm Descriptive Grade (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        989, 
        1010
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        925, 
        930
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1477, 
        1482
      ]
    }
  ], 
  "Relative Location (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        917, 
        924
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1469, 
        1476
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        898, 
        899
      ]
    }
  ], 
  "Supplementary Report Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1091, 
        1123
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PATHLAB_LIS|HOSPITAL 2^9999^MOH|PIMS|CCO-OCR|20160505142000|0042DFD04504A8D0141205796D4D206EFD293C51|ORU^R01|9999999999999999|P|2.5|\nPID|1||999999^^^^CMR^HOSPITAL 2&9999&MOH~999999^^^^MRN^HOSPITAL 2&9999&MOH~9999999999&J&ON^^^^JHN||XXXXXXXX^XXXXXXX||99999999|F|||999 XXXXXXXXXXX XX^^XXXXXX^XX^X9X 9X9^999|||||||||||||||||||N|\nOBR|1||S16-25448|11529-5^Surgical Pathology Study Report^LN^BX^Biopsy^L|||201604200000|||77929^XXXXX^XXXXXX||||201604210944|&Intestine Lg Bx: SIGMOID COLON MASS|99999^XXXXX^XXXXXX||||||201604221440||LS|C|||||||99999^XXX-XXXXX^XXXXX|\n\n\n\n\n\n\n\nPath report.gross description\n\nThe specimen labeled with the patient's name and as \"sigmoid mass BX\" consists of multiple fragments of pink tissue measuring 0.2-0.4 cm received in 10% buffered formalin.\n1A-1B submitted in toto.\n\n\n\n\nPath report.relevant Hx\n\nNot available on the requisition.\n\n\n\nPath report.final diagnosis\n\n1.     Biopsies of sigmoid colon mass: Multiple fragments of partly necrotic tumor showing poorly differentiated \n                   high-grade malignancy; IHC markers to follow by addendum\n\n\n\nPath report.supplemental reports\n\n1A. Marker's and stains applied on this tumor was positive for AE1/AE3 and mucicarmine respectively\n  CD45 and CK 20 were negative. \n  This would favor the diagnosis of poorly differentiated high-grade adenocarcinoma\n\nBiomarker studies will applied on this tumor and separate addendum to follow \n\n\n\nPath report.site of origin\n\nIntestine Lg Bx: SIGMOID COLON MASS\n\n\nPath report.comments\n\nRESULTS\n  Mismatch Repair\n  Immunohistochemistry (IHC) Testing for Mismatch Repair (MMR) Proteins: \n   MLH1\n    -Loss of nuclear expression\n    MSH2\n    -Intact nuclear expression\n    MSH6\n    -Intact nuclear expression\n    PMS2\n    -Loss of nuclear expression\n  IHC Interpretation:   -Loss of nuclear expression of MLH1 and PMS2: testing for methylation of the MLH1 promoter and / or mutation of BRAF is indicated (the presence of a BRAF V600E mutation and / or MLH1 methylation suggests that the tumor is sporadic and germline evaluation is probably not indicated; absence of both MLH1 methylation and of BRAF V600E mutation suggests the possibility of Lynch syndrome and sequencing and / or large deletion / duplication testing of germline MLH1 may be indicated)\n    # Reporting Note: There are exceptions to the above IHC interpretations. These results should not be considered in isolation, and clinical correlation with genetic counseling is recommended to assess the need for germline testing.\n\n\n\n\n"
}